Drug Shortage Report for ORCIPRENALINE

Last updated on 2019-08-22 History
Report ID 77931
Drug Identification Number 02236783
Brand name ORCIPRENALINE
Common or Proper name ORCIPRENALINE
Company Name AA PHARMA INC
Market Status DORMANT
Active Ingredient(s) ORCIPRENALINE SULFATE
Strength(s) 2MG
Dosage form(s) SYRUP
Route of administration ORAL
Packaging size 250ml
ATC code R03CB
ATC description ADRENERGICS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-03-06
Estimated end date 2019-04-05
Actual end date 2019-04-01
Shortage status Resolved
Updated date 2019-08-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2019-08-22 French Compare
v4 2019-08-22 English Compare
v3 2019-03-07 English Compare
v2 2019-03-06 French Compare
v1 2019-03-06 English Compare

Showing 1 to 5 of 5